Bright Minds Biosciences ...

35.34
-1.90 (-5.10%)
At close: Mar 03, 2025, 3:59 PM
34.92
-1.18%
After-hours: Mar 03, 2025, 04:00 PM EST

Bright Minds Biosciences Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a n/a
Operating Income -2.62M -7.2M -14.73M -8.62M -474.93K -236.15K
Interest Income n/a n/a n/a n/a n/a n/a
Pretax Income -2.8M -7.37M -14.96M -8.65M -480.38K -236.15K
Net Income -2.8M -7.37M -14.96M -8.65M -480.38K -236.15K
Selling & General & Admin 1.44M 2.2M 2.55M 2.31M 120.07K 110.12K
Research & Development 1.18M 5M 12.18M 6.31M 354.85K 126.03K
Other Expenses n/a n/a -0.00 0.00 0.00 0.00
Operating Expenses 2.62M 7.2M 14.73M 8.62M 474.93K 236.15K
Interest Expense n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses 41.6K 119.42K 551.86K 852.15K 9.62K n/a
Cost & Expenses 2.62M 7.2M 14.73M 8.62M 474.93K 236.15K
Income Tax n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic) 4.31M 3.72M 2.47M 1.79M 1.28M 1.28M
Shares Outstanding (Diluted) 4.31M 3.72M 2.47M 1.79M 1.28M 1.28M
EPS (Basic) -0.65 -1.98 -6.15 -4.74 -0.38 -0.06
EPS (Diluted) -0.65 -1.98 -6.15 -4.74 -0.38 -0.06
EBITDA n/a -7.28M -14.96M n/a n/a n/a
Depreciation & Amortization 2.62M 72.45K 6.04K 8.62M 474.93K 236.15K